Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2025-04-25 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It references auditing standards and the responsibility of the board and auditors regarding internal control over financial reporting for the fiscal year ending December 31, 2024. The document contains an auditor's opinion on the effectiveness of internal controls. It is a standalone audit report focused on internal control over financial reporting, not a full annual report or other type of filing. The length is short (880 characters), but the content is substantive and includes an audit opinion, so it is not merely an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2024
2025-04-25 Chinese
2024年度独立董事述职报告（张念春）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2024, detailing the independent director's attendance, opinions, and activities related to board meetings and company governance. It includes specific dates and descriptions of opinions on various company matters, but it is not a full financial report or audit report. It is a report on the independent director's duties and governance oversight rather than a financial or audit report. This fits best under Board/Management Information (MANG), which covers announcements or reports related to board members and senior management activities. The document length is short (1679 characters), but it contains substantive content about the director's role and opinions, not just an announcement or certification. Therefore, it is not RNS or RPA. Hence, the classification is MANG with high confidence.
2025-04-25 Chinese
监事会关于《公司2024 年度内部控制自我评价报告》的审核意见
Audit Report / Information Classification · 95% confidence The document is a supervisory board's review opinion on the company's 2024 internal control self-assessment report. It references regulatory standards and confirms the internal control system's adequacy and compliance. The document is short (390 characters) and primarily provides an opinion on an internal control report rather than the report itself. It does not contain financial data or detailed audit results. This fits best under Audit Report / Information (AR), as it relates to internal control evaluation and supervisory board audit opinions, not a full annual report or other categories. FY 2024
2025-04-25 Chinese
2024年年度财务报告
Annual Report Classification · 100% confidence The document is titled as the "2024 年年度财务报告" which translates to "2024 Annual Financial Report" of 中粮生物科技股份有限公司. It contains detailed consolidated and parent company financial statements including balance sheets, profit and loss statements, cash flow statements, and changes in equity for the fiscal year ending December 31, 2024. The length of the document is substantial (15,000 characters) and it includes comprehensive financial data and notes, not just an announcement or summary. There is no indication that this is a certification, announcement, or a supplementary data file. Therefore, this document fits the definition of an Annual Report (10-K) which covers the full financial performance and company activity for the year. FY 2024
2025-04-25 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2024 年度内部控制评价报告' which translates to '2024 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2024. The content includes detailed descriptions of internal control scope, evaluation criteria, defect classifications, and conclusions about the absence of major defects. It is a comprehensive report on internal control evaluation, which is a type of audit-related report but not a full annual report. The document is over 5,000 characters and contains substantive evaluation content, not just an announcement or certification. Therefore, it fits best under the category of Audit Report / Information (AR), which covers standalone audit reports and internal control evaluations. FY 2024
2025-04-25 Chinese
关于公司限制性股票激励计划第四个解锁期解锁条件未成就暨回购注销部分限制性股票的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement regarding the company's restricted stock incentive plan, specifically about the failure to meet the unlocking conditions for the fourth unlocking period and the subsequent repurchase and cancellation of restricted shares. It includes extensive information about board and supervisory committee approvals, legal opinions, and detailed data on the repurchase quantities and affected individuals. The content focuses on management decisions and board resolutions related to stock incentives and repurchases, rather than financial results, earnings, or general regulatory filings. This fits best under the category of Board/Management Information (MANG), as it involves board decisions and management actions concerning stock incentive plans and share repurchases tied to management performance and conditions.
2025-04-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.